Results 181 to 190 of about 28,675 (247)

Patient-reported gradual worsening reveals progression beyond MS subtypes. [PDF]

J Neurol
Guo J, Olsson T, Alfredsson L, Hedström AK.   +3 more
europepmc   +1 more source

Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China. [PDF]

BMC Neurol
Tan H, Zhou L, Gao Y, Zhao C, Lu C, Dong Q, ZhangBao J, Quan C.   +7 more
europepmc   +1 more source

Impact of genetic polymorphisms in the interleukin-18 and interleukin-21 genes on the risk and clinical outcomes of multiple sclerosis. [PDF]

BMC Neurol
Bakr NM, Hashim NA, El-Eshmawy MA, El-Baz HA.   +3 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study. [PDF]

Eur J Neurol
Savolainen M, Soilu-Hänninen M, Nurmi H, Viitala M, Tienari P, Atula S, Laakso SM.   +6 more
europepmc   +1 more source

Therapeutic Outcomes of Fingolimod and Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis: A Real-World Study from Jordan. [PDF]

Medicina (Kaunas)
Al Anber A, Abu Al Karsaneh O, Abuquteish D, Abdallah O, Issa MA, Sa'adeh M, Kilani D.   +6 more
europepmc   +1 more source

Correction: Balancing innovation and affordability in relapsing-remitting multiple sclerosis: a budget impact analysis from Saudi Arabia. [PDF]

Front Public Health
Al-Jedai A, Almudaiheem H, Al-Suweidan FA, Al Jumah M, Al-Thobaiti A, Alzureiqan F, Abu Ras W, Al-Dosari FM, Malik YA, Dhopte P, Ojeil R.   +10 more
europepmc   +1 more source

An Exploratory Cross-Sectional Study of the Association Between Regular Cigarette Smoking and Level of Disability, Hand Dexterity, Cognitive Impairment, Fatigue, and Markers of Oxidative Stress in Male Patients With Relapsing-Remitting Multiple Sclerosis. [PDF]

Am J Mens Health
Ahmadi Bonabi M, Mosaddeghi-Heris R, Taheri N, Talebi M, Naseri A.   +4 more
europepmc   +1 more source

Clocks out of sync: Increased epigenetic aging variability in multiple sclerosis. [PDF]

J Neurol Sci
Schumacher FL, Cutter G, Burd CE, Archer K, Zhang Y.   +4 more
europepmc   +1 more source

T Helper Cells and Cytokine Networks in the Immunopathogenesis of Multiple Sclerosis. [PDF]

Immunotargets Ther
Egba SI, Ikechukwu GC, Okereke CI, Orhonigbe IO, Uroko RI, Ugwu OPC.   +5 more
europepmc   +1 more source